Mahadeo, A.; Tsang, Y.P.; Zheng, A.R.; Arnzen, S.; Rodriguez, A.G.; Warren, M.S.; Gáborik, Z.; Kelly, E.J.
Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A. Pharmaceutics 2025, 17, 1474.
https://doi.org/10.3390/pharmaceutics17111474
AMA Style
Mahadeo A, Tsang YP, Zheng AR, Arnzen S, Rodriguez AG, Warren MS, Gáborik Z, Kelly EJ.
Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A. Pharmaceutics. 2025; 17(11):1474.
https://doi.org/10.3390/pharmaceutics17111474
Chicago/Turabian Style
Mahadeo, Anish, Yik Pui Tsang, Angela R. Zheng, Sydney Arnzen, Acilegna G. Rodriguez, Mark S. Warren, Zsuzsanna Gáborik, and Edward J. Kelly.
2025. "Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A" Pharmaceutics 17, no. 11: 1474.
https://doi.org/10.3390/pharmaceutics17111474
APA Style
Mahadeo, A., Tsang, Y. P., Zheng, A. R., Arnzen, S., Rodriguez, A. G., Warren, M. S., Gáborik, Z., & Kelly, E. J.
(2025). Human OAT1, OAT3, OAT4 and OATP1A2 Facilitate the Renal Accumulation of Ochratoxin A. Pharmaceutics, 17(11), 1474.
https://doi.org/10.3390/pharmaceutics17111474